CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/[mu]L.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Works matching IS 14642662 AND DT 2006 AND VI 7 AND IP 6
Results: 13
1
2
Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 411, doi. 10.1111/j.1468-1293.2006.00389.x
- By:
- Publication type:
- Article
3
Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 347, doi. 10.1111/j.1468-1293.2006.00390.x
- By:
- Publication type:
- Article
4
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 351, doi. 10.1111/j.1468-1293.2006.00391.x
- By:
- Publication type:
- Article
5
Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 356, doi. 10.1111/j.1468-1293.2006.00392.x
- By:
- Publication type:
- Article
6
Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 361, doi. 10.1111/j.1468-1293.2006.00394.x
- By:
- Publication type:
- Article
7
The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 369, doi. 10.1111/j.1468-1293.2006.00395.x
- By:
- Publication type:
- Article
8
Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 378, doi. 10.1111/j.1468-1293.2006.00396.x
- By:
- Publication type:
- Article
9
CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 383, doi. 10.1111/j.1468-1293.2006.00397.x
- By:
- Publication type:
- Article
10
Fulminant toxoplasmosis causing fatal pneumonitis and myocarditis.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 415, doi. 10.1111/j.1468-1293.2006.00393.x
- By:
- Publication type:
- Article
11
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 404, doi. 10.1111/j.1468-1293.2006.00400.x
- By:
- Publication type:
- Article
12
Abnormal glucose metabolism among older men with or at risk of HIV infection.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 389, doi. 10.1111/j.1468-1293.2006.00398.x
- By:
- Publication type:
- Article
13
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
- Published in:
- HIV Medicine, 2006, v. 7, n. 6, p. 397, doi. 10.1111/j.1468-1293.2006.00399.x
- By:
- Publication type:
- Article